Discover the 2017 preliminary agenda

Please note that this agenda is not final.

TRACK 1 – NEW PLAYERS INVOLVED IN INNOVATION IN THE HEALTH SECTOR

TRACK 2 – NURTURING AND LICENSING EARLY-STAGE ASSETS

TRACK 3 – BIOENTREPRENEURS’ CHALLENGES AT PRE-SEED, SEED AND SERIES A STAGES


DAY ONE – 28th Nov. 2017

Conferences and roundtable discussions

Presentation sessions

Partnering

Hosted event

8.30am
9.30am

REGISTRATION AND WELCOME

SIMV

9.30am
11.00am

How can collaborations in rare diseases be an asset in a highly competitive yet fast moving market?

Shared risk or competition for emerging assets: How should the pharma-VC relationship function?

Licensing Opportunity Presentations

one-to-one meeting, meetings, biofit, biofit 2017

One-to-one meetings

R&D dating for animal health and innovation

11.00am
11.30am

NETWORKING BREAK

BREAK

11.30am
1.00pm

PLENARY SESSION

How can we overcome the shortage
of bioentrepreneurs in Europe?

1.00pm
2.30pm

LUNCH

LUNCH

2.30pm
3.00pm

Crash course: How to value your start-up?

3.00pm
4.30pm

Exploring the growing relationship between pharma, digital health companies and data providers

Assessing the opportunity in licensing early-stage projects

Start-up Slams

one-to-one meeting, meetings, biofit, biofit 2017

One-to-one meetings

R&D dating for animal health and innovation

4.30pm
5.00pm

NETWORKING BREAK

BREAK

5.00pm
6.30pm

Focused therapeutic funds: Is this the new trend in financing early-stage innovation?

Licensing Opportunity Presentations

R&D dating for animal health and innovation

7.00pm

BIOPARTY


DAY TWO – 29th Nov. 2017

Conferences and roundtable discussions

Presentation sessions

Partnering

Hosted event

8.30am
9.00am

REGISTRATION AND WELCOME

SIMV

9.00am
10.30am

How are collaborations key to improve innovation in metabolic diseases?

How can we encourage the founding scientists to remain committed?

Start-up Slams

R&D dating for animal health and innovation

10.30am
11.00am

NETWORKING BREAK

BREAK

11.00am
12.30pm

How can animal innovation and human applications be mutually beneficial?

Where will European
pre-seed, seed and Series A investment go in 2018?

Licensing Opportunity Presentations

one-to-one meeting, meetings, biofit, biofit 2017

One-to-one meetings

R&D dating for animal health and innovation

12.30pm
2.00pm

LUNCH

LUNCH

2.00pm
3.30pm

Which role to play for the TTO in the early development of the spin off?

Start-up Slams

R&D dating for animal health and innovation

3.30pm
4.30pm

How can we define a mutually beneficial collaboration between a start-up and the originating academic institution?